Trials / Not Yet Recruiting
Not Yet RecruitingNCT07092722
Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males
A Randomized, Double Blind, Placebo Controlled Parallel Arm Clinical Study to Evaluate the Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- GENCOR Lifestage Solutions · Academic / Other
- Sex
- Male
- Age
- 36 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The Purpose of the study is to evaluate the efficacy of LN18178 in improving muscle strength, aerobic capacity and body composition in healthy young males.
Detailed description
A total of 120 male subjects aged between 36 and 50 years will be included in the study. Assessment of inclusion and exclusion criteria will be done based on clinical and laboratory investigations. The eligible subjects will be randomized as per the computer-generated randomization list. The subjects will be assigned to either LN18178:400 mg or Placebo at 1:1 ratio. The subjects will be instructed to take one capsule daily in the morning after breakfast with water for 12 weeks. Apart from primary and secondary outcomes, the study will also record the vital signs and adverse events to evaluate the herbal composition safety and tolerability. The safety assessment of the LN18178 will also include routine laboratory investigations on blood, urine and clinical chemistry at screening and the final visit of the intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | LN18178 | 400 mg, One capsule to be consumed in the morning after breakfast with water for 12 Weeks |
| DIETARY_SUPPLEMENT | Placebo | One capsule to be consumed in the morning after breakfast with water for 12 Weeks |
Timeline
- Start date
- 2025-08-04
- Primary completion
- 2026-01-15
- Completion
- 2026-01-15
- First posted
- 2025-07-30
- Last updated
- 2025-07-30
Source: ClinicalTrials.gov record NCT07092722. Inclusion in this directory is not an endorsement.